United Orthopedic Corporation (TPEX:4129)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
99.70
+1.60 (1.63%)
May 8, 2026, 1:30 PM CST

United Orthopedic Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
9,61510,8018,8977,4453,7342,461
Market Cap Growth
18.41%21.39%19.51%99.39%51.75%-24.76%
Enterprise Value
11,11512,27710,4108,9685,1003,638
Last Close Price
99.70112.0088.8678.6342.8428.23
PE Ratio
17.5819.2219.4919.6116.8585.23
Forward PE
14.2924.0924.0924.0924.0924.09
PS Ratio
1.701.911.911.891.180.96
PB Ratio
2.292.572.252.071.210.87
P/TBV Ratio
2.642.962.622.501.521.14
P/FCF Ratio
28.3931.8946.11-69.5817.26
P/OCF Ratio
9.3710.5312.4017.1610.467.19
PEG Ratio
-1.201.201.201.201.20
EV/Sales Ratio
1.972.172.242.281.611.42
EV/EBITDA Ratio
9.229.9510.119.947.958.31
EV/EBIT Ratio
16.4816.5817.0916.5114.9322.54
EV/FCF Ratio
32.8236.2553.95-95.0525.52
Debt / Equity Ratio
0.490.490.470.450.510.61
Debt / EBITDA Ratio
1.621.621.751.752.353.71
Debt / FCF Ratio
6.086.089.65-29.2812.07
Net Debt / Equity Ratio
0.330.330.310.330.380.38
Net Debt / EBITDA Ratio
1.131.131.211.301.812.47
Net Debt / FCF Ratio
4.124.126.43-14.7421.617.60
Asset Turnover
0.760.760.690.650.580.48
Inventory Turnover
0.640.640.580.600.670.65
Quick Ratio
0.830.830.750.840.740.66
Current Ratio
1.721.721.551.791.521.25
Return on Equity (ROE)
14.02%14.02%12.21%11.62%7.57%1.84%
Return on Assets (ROA)
6.23%6.23%5.66%5.64%3.93%1.86%
Return on Invested Capital (ROIC)
10.17%10.37%9.79%9.19%6.18%2.90%
Return on Capital Employed (ROCE)
13.90%13.90%13.30%12.00%8.80%4.90%
Earnings Yield
5.85%5.21%5.13%5.16%5.93%2.12%
FCF Yield
3.52%3.14%2.17%-1.07%1.44%5.79%
Dividend Yield
4.51%4.02%4.50%5.09%5.84%-
Payout Ratio
68.60%68.60%84.54%52.21%-169.83%
Buyback Yield / Dilution
-4.41%-4.41%-3.31%-5.60%-12.77%11.73%
Total Shareholder Return
0.10%-0.39%1.20%-0.51%-6.94%11.73%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.